APN
APN
APN - Aspen Pharmacare Holdings Limited - Trading update
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")
Trading update
Aspen shareholders are hereby advised that earnings per share, for the 12 months
ended 30 June 2011, are expected to exceed those reported in the comparative
period, ended 30 June 2010, by 18% to 22%. Headline earnings per share is
expected to be below this range.
Headline earnings per share from continuing operations, adjusted for transaction
and restructure costs mainly related to the acquisition of the pharmaceutical
division of Sigma Pharmaceuticals Limited in Australia, is expected to exceed
those of the comparative period by 18% to 22%.
The financial results on which this trading announcement is based have not been
reviewed or reported on by Aspen`s external auditors
Aspen`s results are scheduled to be published on SENS on 13 September 2011.
Woodmead
2 September 2011
Sponsor: Investec Bank Limited
Date: 02/09/2011 10:33:02 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
